Cargando…
Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?
Biologic reference drugs and their copies, biosimilars, have a complex structure. Biosimilars need to demonstrate their biosimilarity during development but unpredictable variations can remain, such as micro-heterogeneity. The healthcare community may raise questions regarding the clinical outcomes...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796345/ https://www.ncbi.nlm.nih.gov/pubmed/33383867 http://dx.doi.org/10.3390/ijerph18010186 |